Danaher Co. (NYSE:DHR)’s stock price reached a new 52-week high during trading on Tuesday . The company traded as high as $160.97 and last traded at $159.81, with a volume of 259140 shares changing hands. The stock had previously closed at $159.57.

DHR has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. upped their price target on shares of Danaher from $155.00 to $175.00 in a report on Thursday, December 19th. Royal Bank of Canada reissued a “hold” rating and set a $145.00 price objective on shares of Danaher in a research report on Wednesday, December 18th. Stifel Nicolaus reissued a “hold” rating and set a $150.00 price objective on shares of Danaher in a research report on Thursday, November 14th. Wells Fargo & Co initiated coverage on shares of Danaher in a research report on Tuesday, January 7th. They set an “overweight” rating and a $170.00 price objective on the stock. Finally, ValuEngine downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Six research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company’s stock. The company has a consensus rating of “Buy” and an average price target of $158.38.

The company has a debt-to-equity ratio of 0.52, a quick ratio of 3.09 and a current ratio of 3.43. The stock’s 50-day simple moving average is $151.28 and its 200-day simple moving average is $143.07. The firm has a market capitalization of $113.57 billion, a PE ratio of 35.59, a P/E/G ratio of 2.48 and a beta of 0.93.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Thursday, October 24th. The conglomerate reported $1.16 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.15 by $0.01. The business had revenue of $5.04 billion for the quarter, compared to the consensus estimate of $5.02 billion. Danaher had a net margin of 12.13% and a return on equity of 11.42%. The company’s quarterly revenue was up 3.8% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.10 EPS. As a group, analysts predict that Danaher Co. will post 4.74 earnings per share for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Friday, December 27th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 0.42%. The ex-dividend date of this dividend is Thursday, December 26th. Danaher’s dividend payout ratio is presently 15.04%.

Large investors have recently added to or reduced their stakes in the company. Barings LLC grew its position in shares of Danaher by 8.7% in the 2nd quarter. Barings LLC now owns 11,922 shares of the conglomerate’s stock worth $1,703,000 after buying an additional 952 shares during the period. Comerica Bank grew its position in Danaher by 1.0% during the 3rd quarter. Comerica Bank now owns 158,507 shares of the conglomerate’s stock valued at $21,626,000 after purchasing an additional 1,541 shares during the last quarter. National Pension Service grew its position in Danaher by 5.2% during the 2nd quarter. National Pension Service now owns 665,852 shares of the conglomerate’s stock valued at $95,164,000 after purchasing an additional 33,165 shares during the last quarter. Eastern Bank grew its position in Danaher by 2.1% during the 3rd quarter. Eastern Bank now owns 129,991 shares of the conglomerate’s stock valued at $18,775,000 after purchasing an additional 2,698 shares during the last quarter. Finally, Bourgeon Capital Management LLC grew its position in Danaher by 0.4% during the 3rd quarter. Bourgeon Capital Management LLC now owns 55,684 shares of the conglomerate’s stock valued at $8,042,000 after purchasing an additional 230 shares during the last quarter. 77.99% of the stock is currently owned by hedge funds and other institutional investors.

About Danaher (NYSE:DHR)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company's Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables.

See Also: Green Investing

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.